RxDoctor Payments DataLook up a doctor →

Angela Sanders, NP

Adult Health · Danville, INNPI 1407256613

Payments from drug & device makers

$9,717in general payments, 2019–2025

Across 352 payments — averaging $27.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AstraZeneca$747
  • Johnson & Johnson$562
  • Merck$473
  • Eisai Inc.$447
  • Pfizer$434
  • plus $5K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis62$1,775
AstraZeneca(2 entities)32$747
Johnson & Johnson(2 entities)13$562
Merck20$473
Eisai Inc.21$447
Pfizer25$434
Astellas Pharma US Inc6$414
Amgen6$400
Seagen Inc.7$301
Incyte Corporation11$292
E.r. Squibb & Sons, L.L.C.8$270
Daiichi Sankyo Inc.10$257
Lilly USA, LLC11$256
Sanofi6$189
Takeda Pharmaceuticals U.S.A., Inc.6$183
AbbVie8$175
Exelixis Inc.5$168
Jazz Pharmaceuticals Inc.6$166
Gilead5$155
Bristol Myers Squibb8$153
Beigene USA, Inc.3$116
Sanofi-aventis U.S. LLC1$100
Global Blood Therapeutics, Inc.2$99
Acrotech Biopharma Inc.5$98
Genentech USA, Inc.6$97
Coherus Oncology, Inc.4$96
Sobi, Inc1$85
Tersera Therapeutics LLC3$84
Pharmacosmos Therapeutics Inc.4$84
Rigel Pharmaceuticals, Inc.3$82
Ipsen Biopharmaceuticals, Inc3$71
Pharmaessentia USA Corporation3$69
Boehringer Ingelheim3$66
Genmab U.S., Inc.3$64
Taiho Oncology, Inc.2$53
Pharmacyclics LLC, An Abbvie Company3$52
Adaptive Biotechnologies Corporation2$47
Agios Pharmaceuticals, Inc.2$45
EMD Serono, Inc.2$41
Regeneron Healthcare Solutions, Inc.1$37
Mirati Therapeutics, Inc.1$34
GSK2$32
Geron Corporation1$32
Corcept Therapeutics1$29
CTI Biopharma Corp.1$29
Morphosys, US Inc.2$28
Iovance Biotherapeutics, Inc.1$25
Immunocore Limited1$23
Stemline Therapeutics Inc.1$22
Foundation Medicine, Inc.1$21
Sun Pharmaceutical Industries Inc.1$20
Puma Biotechnology, Inc.1$19
Recordati_rare_diseases_inc.1$18
Apellis Pharmaceuticals, Inc.1$18
Legend Biotech USA Inc.1$16
Beone Medicines USA, Inc.1$16
Kyowa Kirin, Inc.1$16
Shield Therapeutics Inc1$15

How this compares

$9,717 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana →

Medicare billing

Part B allowed, 2024
$18,484
Medicare patients
131
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Danville

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →